Pär Myrelid

Professor of Surgery and Consultant Colorectal Surgeon
Linköping University Hospital and
Dept of Experimental Medicine, Linköping University, Sweden

[Pär Myrelid @PMyrelid]

Soon after Elin Moltubak also received prize for best PhD thesis. Congratulations to all of you!
@SKFstyrelse @SKFredaktion @KalleLanderholm Caroline Nordenvall @rollanders @PamelaBuchwald @liu_universitet @regionost @regionjkpg

[Pär Myrelid @PMyrelid]

Jackpot! Excellent work by @elinmoltu Hussein Faysal Emelie Wiktorson. All three nominated for @BJSurgery @BJSAcademy Prize Session at #Kirurgveckan (out of four nominations) and then first AND second prize for Faysal and @elinmoltu respectively.

[Pär Myrelid @PMyrelid]

@SeanLangenfeld @rbarbosa91 @JBMatthews @JohnRTMonsonMD @TomVargheseJr @jdimick1 @juliomayol @ScottRSteeleMD @NirajGusani @ericpaulimd I took altogether 18 months off to spend with my three kids when they were babies. Older colleagues shock their heads and sighed. I think surgeyvhas changed, and for the better. More interdisciplinary teamwork, better selection, more super specialists, and better referal pattern.

[Pär Myrelid @PMyrelid]

@SeanLangenfeld @rbarbosa91 @JBMatthews @JohnRTMonsonMD @TomVargheseJr @jdimick1 @juliomayol @ScottRSteeleMD @NirajGusani @ericpaulimd You could also add to this issue of hours needed that a country like Sweden has adopted the EU work hour limit, and even before that had a human limit of hours, and still has aning the best surgical results across the field. Add to this that we also have more time off as parents.

[#MondayNightIBD @MondayNightIBD]

The polls are glitching but we keep on going🥁

🌟Insights from GI, CRSurgery, PharmD & more

🎯Managing #IBD in older pts

🗳️Pls help @AdamFayeMD better understand how we weigh options in older pts (& advance science together)
👉🏽https://t.co/7hRFbTEhwX

✅#IBDAlgo👇🏽 @BassiMehak

[Pär Myrelid @PMyrelid]

@DCharabaty @AdamFayeMD @MondayNightIBD @abbvie @JNJInnovation @TakedaPharma @DrJordanAxelrad @JeanFredericCo1 @IBDimmunology @DrsMeena @clivejmiranda @datadriven_tdoc @IBD_FloMD @JHashashMD @MLongMD @DavidHudesmanMD @shannonchangmd @SimonHongMD @HolmerMd @DrMikeDolinger @ryanungaro @EdwardLoftus2 @EdBarnesMD @BenClickMD @fudmanMD @tommasoparigi @AndresYarur @ownyourcrohns @JustinFieldMD @MeganMurphyGI @AmyStewartNP @LindsayClarkeMD @KDeFelice_IBD @AimenKhanMD @EdithHoMD @IBD_DrEMF @IBDPharmD @ElisaBodenIBDMD @SalamBachour @RahulSDalalMD @md_ayanna @SchwartzbergMD @HolubarStefan Completely agree with @SchwartzbergMD Optimisation of the nutritional status is often missed. Minimizes risks and also often permits tapering steroids, with simular short term aleviating effect on symptoms. Then MIS.

[Pär Myrelid @PMyrelid]

@RPanaccione @AnthonydeBuck @ClevelandClinic @DavidLiskaMD @IBD_FloMD @MRegueiroMD @HolubarStefan Refractory pouchitis is for sure one category as surgical treatment otherwise means remiving the normal bowel leaving the inflamed as step 1. Then restore with a pouch. Well worth trying appendectomy.

[Stefan Holubar MD MS @HolubarStefan]

Hot off press #ECCO2026 @Sweden 🇸🇪 KPIPS Key Performance Indicators in Pouch Surg - THANK YOU #GlobalIBD community for participating #IPAA #HolubarPouchLab @ClevelandClinic @PMyrelid @AntoninoSpin @DHahnloser
@philtozer1 @MichelAdamina @nlavellaneda
#SoMe4IBD #SoMe4Surgery

[Alaa El-Hussuna @AlaaEl_Hussuna]

S-ECCO Masterclass in IBD #Surgery 2026

This year’s Masterclass goes beyond purely surgical forum

It is a well-structured educational activity fully integrated into the ECCO #ecosystem, with active participation from pathologists, gastroenterologists, endoscopists & dietitians

[Pär Myrelid @PMyrelid]

A big thank you to @LilliLundby , @philtozer1 and the team at #Sacomed for making out fistula workshop in Linköping a sucess. Also a big thank you to all participants and the team at our day care surgery unit.

[United European Gastroenterology @my_ueg]

🎓 This weekend, we wrapped up the UEG Masterclass 2025 on IBD in Vienna!

A huge thank you to our Course Directors, @DignassAxel​ and @VavrickaStephan​, our outstanding faculty, and nearly 50 enthusiastic participants for making this event a success. 📸

[Paulo G. Kotze @pakotze]

Out now at @UEGJournal the global perspective of pregnancy and lactation in IBD patients.

https://t.co/E5kDCihaHd

@geteccu Outstanding work from Maria Jose Casanova and Maria Chaparro.

[Stefan Holubar MD MS @HolubarStefan]

Dear Global #IBD Community: are you an IBD-surgeon / IBD-GI interested in #IPAA #JPouch #Pouchology #IBDSurgery?

If so => DM me for link to KPIPS survey before Round 1 closes

So far: >125 responses / 22 countries / 19 States

66% Colorectal, 33% GI

#SoMe4IBD #SoMe4Surgery

[Steven D Wexner MD, PhD @SWexner]

Chance of pouch surgery after colectomy for ulcerative colitis based on pelvic pouch volumes at the colectomy hospital, a Swedish national cohort study https://t.co/aPYuVGGMn5 open access @ColorectalDis

[ZoeGaroufalia @ZGaroufalia]

Kudos to @yazmaeda for delivering a fantastic course on peer review with @ColorectalDis and @escp_tweets 👏
Thoroughly enjoyed the discussions and the vibrant brainstorming with such an engaged audience!

Stay tuned for ESCP 2026

[Pär Myrelid @PMyrelid]

@SWexner @ColorectalDis @ACPGBI @escp_tweets @coloproctoaec A great collaboration from the surgeons of the Swedish Organisation of Inflammatory Bowel Disease. In memoriam of Mattias Block.

[Steven D Wexner MD, PhD @SWexner]

Long‐term perineal wound healing and re‐operation rates after proctectomy in patients with inflammatory bowel disease—A retrospective multicentre study https://t.co/fHngezGWsg @ColorectalDis OPEN ACCESS @ACPGBI @escp_tweets @coloproctoaec

[IA (Ileostomy and Internal Pouch Association) @iasupport]

Join us for Pouch Information Day!

Ask questions, speak openly, and learn from professionals and experienced pouch owners.

Open to anyone with an interest in internal pouches.

Please visit our website to learn more: https://t.co/uWzvd7IbrT

#InternalPouch

[Dr Mark Silverberg @guthealthmd]

Incredibly important study. The elephant in the room. Do clinical trials actually provide the justification to treat patients the way we do. The whole “off label” discussion is misconstrued. Pretty much every pt we treat is off label because they would not have been eligible for a trial. The RCTs give us basic safety and efficacy signals. We need more flexibility when we use these therapies in real world practice.